An endocrinologist should be consulted for women with hypothyroidism who are planning pregnancy. According to a review in the British Journal of General Practice, their levothyroxine dose should be adjusted to maintain a preconception TSH concentration of less than 2.5 mu/L. Upon conception, the daily dose of levothyroxine should be increased by 25-50 mcg and thyroid function should be monitored to ensure TSH remains below 2.5 mU/L. Therefore, increasing the dose to 100 mcg levothyroxine daily would be the correct course of action, while doubling the dose may be too large an increase. It would be inappropriate to reduce, stop, or maintain the same medication dosage as thyroxine requirements increase during pregnancy.

During pregnancy, there is an increase in the levels of thyroxine-binding globulin (TBG), which causes an increase in the levels of total thyroxine. However, this doesn’t affect the free thyroxine level. If left untreated, thyrotoxicosis can increase the risk of fetal loss, maternal heart failure, and premature labor. Graves’ disease is the most common cause of thyrotoxicosis during pregnancy, but transient gestational hyperthyroidism can also occur due to the activation of the TSH receptor by HCG. Propylthiouracil has traditionally been the antithyroid drug of choice, but it is associated with an increased risk of severe hepatic injury. Therefore, NICE Clinical Knowledge Summaries recommend using propylthiouracil in the first trimester and switching to carbimazole in the second trimester. Maternal free thyroxine levels should be kept in the upper third of the normal reference range to avoid fetal hypothyroidism. Thyrotrophin receptor stimulating antibodies should be checked at 30-36 weeks gestation to determine the risk of neonatal thyroid problems. Block-and-replace regimens should not be used in pregnancy, and radioiodine therapy is contraindicated.

On the other hand, thyroxine is safe during pregnancy, and serum thyroid-stimulating hormone should be measured in each trimester and 6-8 weeks postpartum. Women require an increased dose of thyroxine during pregnancy, up to 50% as early as 4-6 weeks of pregnancy. Breastfeeding is safe while on thyroxine. It is important to manage thyroid problems during pregnancy to ensure the health of both the mother and the baby.

Understanding Crohn’s Disease

Crohn’s disease is a type of inflammatory bowel disease that can affect any part of the digestive tract, from the mouth to the anus. The exact cause of Crohn’s disease is unknown, but there is a strong genetic component. Inflammation occurs in all layers of the affected area, which can lead to complications such as strictures, fistulas, and adhesions.

Symptoms of Crohn’s disease typically appear in late adolescence or early adulthood and can include nonspecific symptoms such as weight loss and lethargy, as well as more specific symptoms like diarrhea, abdominal pain, and perianal disease. Extra-intestinal features, such as arthritis, erythema nodosum, and osteoporosis, are also common in patients with Crohn’s disease.

To diagnose Crohn’s disease, doctors may look for raised inflammatory markers, increased faecal calprotectin, anemia, and low levels of vitamin B12 and vitamin D. It’s important to note that Crohn’s disease shares some features with ulcerative colitis, another type of inflammatory bowel disease, but there are also important differences between the two conditions. Understanding the symptoms and diagnostic criteria for Crohn’s disease can help patients and healthcare providers manage this chronic condition more effectively.

Breastfeeding and its Effects on Infant Health: A Comprehensive Overview

Breastfeeding has numerous benefits for infant health, including protection against sudden infant death syndrome (SIDS), many infections, childhood obesity, and future type 1 and 2 diabetes. While exclusive breastfeeding has the strongest protective effect against SIDS, any amount of breastfeeding can confer some protection. However, there is no evidence that exclusive breastfeeding protects against atopic eczema.

Breastfeeding may also affect neonatal jaundice. Breastfeeding jaundice, which occurs before the mother’s milk supply is fully developed, can make physiological jaundice appear worse. Breastmilk jaundice, on the other hand, is different and typically peaks between days 5 and 15 before becoming normal after week 3. It may persist up to age 3 months, and its cause is unclear.

Breastfeeding may also have implications for maternal bacterial infections, including tuberculosis. If the mother develops tuberculosis, temporarily stopping breastfeeding may be appropriate, but anti-tuberculosis drugs are safe for use with breastfeeding. Breastmilk is also low in vitamin D, so breastfed infants may need to receive vitamin D drops from 1 month of age if their mother has not taken supplements during pregnancy. This is particularly important for mothers at high risk of vitamin D deficiency.

Overall, breastfeeding has numerous benefits for infant health, but it is important to be aware of its potential implications for certain conditions.

Clopidogrel: An Antiplatelet Agent for Cardiovascular Disease

Clopidogrel is a medication used to manage cardiovascular disease by preventing platelets from sticking together and forming clots. It is commonly used in patients with acute coronary syndrome and is now also recommended as a first-line treatment for patients following an ischaemic stroke or with peripheral arterial disease. Clopidogrel belongs to a class of drugs called thienopyridines, which work in a similar way. Other examples of thienopyridines include prasugrel, ticagrelor, and ticlopidine.

Clopidogrel works by blocking the P2Y12 adenosine diphosphate (ADP) receptor, which prevents platelets from becoming activated. However, concurrent use of proton pump inhibitors (PPIs) may make clopidogrel less effective. The Medicines and Healthcare products Regulatory Agency (MHRA) issued a warning in July 2009 about this interaction, and although evidence is inconsistent, omeprazole and esomeprazole are still cause for concern. Other PPIs, such as lansoprazole, are generally considered safe to use with clopidogrel. It is important to consult with a healthcare provider before taking any new medications or supplements.

Neonatal sepsis is a serious bacterial or viral infection in the blood that affects babies within the first 28 days of life. It is categorized into early-onset (EOS) and late-onset (LOS) sepsis, with each category having distinct causes and presentations. The most common causes of neonatal sepsis are group B streptococcus (GBS) and Escherichia coli. Premature and low birth weight babies are at higher risk, as well as those born to mothers with GBS colonization or infection during pregnancy. Symptoms can range from subtle signs of illness to clear septic shock, and may include respiratory distress, jaundice, seizures, and poor feeding. Diagnosis is usually established through blood culture, and treatment involves early identification and use of intravenous antibiotics. Other important management factors include maintaining adequate oxygenation and fluid/electrolyte status, and preventing or managing hypoglycemia and metabolic acidosis.

Understanding and Managing Lyme Disease: Early Manifestations and Treatment Options

Lyme disease is a tick-borne illness caused by the spirochete Borrelia burgdorferi. Its early manifestation is erythema chronicum migrans, which can progress to neurological, cardiovascular, or arthritic symptoms. Different strains of Borrelia spp. cause varying clinical manifestations, leading to differences in symptoms between countries. The disease is transmitted by Ixodes spp. or deer ticks. Early use of antibiotics can prevent persistent, recurrent, and refractory Lyme disease. Antibiotics shorten the clinical course and progression.

In patients with erythema migrans alone, oral drug therapies can be started in primary care. Doxycycline (100 mg twice daily or 200 mg once daily for 21 days) is the first choice for patients aged 12 years or older. Amoxicillin (1 g three times daily for 21 days) is the first alternative, while azithromycin (500 mg daily for 17 days) is the second alternative but should be avoided in patients with cardiac abnormalities caused by Lyme disease. If there is any suggestion of cellulitis, co-amoxiclav or amoxicillin and flucloxacillin alone would be more appropriate.

In the USA, a single dose of 200 mg of doxycycline within 72 hours of tick removal can prevent Lyme disease from developing. However, the risk in the UK is not high enough to warrant prophylactic antibiotics. Antibody testing in patients with erythema migrans is unhelpful as the rash develops before the antibodies. It is important to discuss management with a microbiologist, especially if there are further manifestations. Early diagnosis and treatment can prevent complications and improve outcomes.

PCV in addition to the 6-1 vaccine (which includes protection against diphtheria, tetanus, whooping cough, polio, Hib, and hepatitis B).

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at specific intervals. At 12-13 months, the Hib/Men C, MMR, PCV, and Men B vaccines are given. At 3-4 years, the ‘4-in-1 Preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine is also offered to new students up to the age of 25 years at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine, while students going to university or college for the first time should contact their GP to have the vaccine before the start of the academic year.

The Men C vaccine used to be given at 3 months but has now been discontinued as there are almost no cases of Men C disease in babies or young children in the UK. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Given his background, he is a suitable candidate for a formal evaluation of his risk for cardiovascular disease through a lipid profile, which can provide additional information to enhance the QRISK2 score.

Management of Hyperlipidaemia: NICE Guidelines

Hyperlipidaemia, or high levels of lipids in the blood, is a major risk factor for cardiovascular disease (CVD). In 2014, the National Institute for Health and Care Excellence (NICE) updated their guidelines on lipid modification, which caused controversy due to the recommendation of statins for a significant proportion of the population over the age of 60. The guidelines suggest a systematic strategy to identify people over 40 years who are at high risk of CVD, using the QRISK2 CVD risk assessment tool. A full lipid profile should be checked before starting a statin, and patients with very high cholesterol levels should be investigated for familial hyperlipidaemia. The new guidelines recommend offering a statin to people with a QRISK2 10-year risk of 10% or greater, with atorvastatin 20 mg offered first-line. Special situations, such as type 1 diabetes mellitus and chronic kidney disease, are also addressed. Lifestyle modifications, including a cardioprotective diet, physical activity, weight management, alcohol intake, and smoking cessation, are important in managing hyperlipidaemia.

Assessing Patients with Atrial Fibrillation

When assessing patients with atrial fibrillation, it is crucial to identify any underlying causes. While some cases may be classified as lone AF, addressing any precipitating factors is the first step in treatment. Hyperthyroidism is a common cause of atrial fibrillation, and checking thyroid function tests is the next appropriate step in diagnosis. Other common causes include heart failure, myocardial infarction/ischemia, mitral valve disease, pneumonia, and alcoholism. Rarer causes include pericarditis, endocarditis, cardiomyopathy, sarcoidosis, and hemochromatosis.

For paroxysmal arrhythmias, a 24-hour ECG can be useful, but in cases of persistent atrial fibrillation, an ECG is not necessary. Exercise tolerance tests are used to investigate and risk-stratify patients with cardiac chest pain. While an echocardiogram is useful in patients with atrial fibrillation to look for valve disease and other structural abnormalities, it is not the next most appropriate investigation in this case. Overall, identifying the underlying cause of atrial fibrillation is crucial in determining the appropriate treatment plan.

Interactions with Warfarin: Understanding the Effects of Carbamazepine, Alcohol, Clarithromycin, Prednisolone, and Sertraline

Warfarin is a commonly prescribed anticoagulant medication that requires careful monitoring to ensure its effectiveness and safety. However, several factors can interact with warfarin and affect its metabolism and anticoagulant effect. Here are some examples:

Carbamazepine is a medication used to manage trigeminal neuralgia, but it is also a hepatic enzyme inducer. This means that it can accelerate the metabolism of warfarin, leading to a reduced effect and a decreased international normalized ratio (INR).

Alcohol consumption can enhance the effects of warfarin, which can increase the risk of bleeding. Therefore, patients on warfarin should avoid heavy drinking or binge drinking.

Clarithromycin is an antibiotic that may be prescribed for a COPD exacerbation. However, it is associated with reduced warfarin metabolism and enhanced anticoagulant effect, which can lead to a raised INR.

Prednisolone is a steroid medication that may also be prescribed for a COPD exacerbation. It is associated with an enhanced anticoagulant effect, which can increase the risk of bleeding when taken with warfarin.

Sertraline is an antidepressant medication that belongs to the selective serotonin reuptake inhibitor (SSRI) class. SSRIs have an antiplatelet effect, which can also increase the risk of bleeding when taken with warfarin.

In summary, understanding the interactions between warfarin and other medications or substances is crucial for managing its anticoagulant effect and preventing adverse events. Patients on warfarin should always inform their healthcare providers of any new medications or supplements they are taking to avoid potential interactions.

There is not enough evidence to recommend any specific treatment for recurrent BV in primary care. However, in women with an intrauterine contraceptive device and persistent BV, it may be advisable to remove the device and suggest an alternative form of contraception.

Bacterial vaginosis (BV) is a condition where there is an overgrowth of anaerobic organisms, particularly Gardnerella vaginalis, in the vagina. This leads to a decrease in the amount of lactobacilli, which produce lactic acid, resulting in an increase in vaginal pH. BV is not a sexually transmitted infection, but it is commonly seen in sexually active women. Symptoms include a fishy-smelling vaginal discharge, although some women may not experience any symptoms at all. Diagnosis is made using Amsel’s criteria, which includes the presence of thin, white discharge, clue cells on microscopy, a vaginal pH greater than 4.5, and a positive whiff test. Treatment involves oral metronidazole for 5-7 days, with a cure rate of 70-80%. However, relapse rates are high, with over 50% of women experiencing a recurrence within 3 months. Topical metronidazole or clindamycin may be used as alternatives.

Bacterial vaginosis during pregnancy can increase the risk of preterm labor, low birth weight, chorioamnionitis, and late miscarriage. It was previously recommended to avoid oral metronidazole in the first trimester and use topical clindamycin instead. However, recent guidelines suggest that oral metronidazole can be used throughout pregnancy. The British National Formulary (BNF) still advises against using high-dose metronidazole regimens. Clue cells, which are vaginal epithelial cells covered with bacteria, can be seen on microscopy in women with BV.

Treatment Options for Paget’s Disease: Bisphosphonates, Calcium and Vitamin D, Co-codamol, NSAIDs, and Prednisolone

Paget’s disease is a condition that requires treatment to control pain and reduce disease progression and complications. The drug of choice for this condition is oral or intravenous bisphosphonates, which reduce bone turnover and improve bone pain, promoting the healing of osteolytic lesions and the restoration of normal bone histology. However, some progression may still occur, and monitoring of serum alkaline phosphatase is necessary to assess treatment effectiveness and disease activity. Patients must be kept under review due to the risk of osteosarcoma, which is suggested by increased bone pain that is poorly responsive to treatment, local swelling, and sometimes a pathological fracture.

While calcium and vitamin D may be necessary to correct any deficiencies before commencing bisphosphonate treatment, they are not the primary treatment options for Paget’s disease. Pain relief may be achieved with paracetamol (or co-codamol) and non-steroidal anti-inflammatory drugs (NSAIDs). However, prednisolone is not used in this condition.

Autonomic Neuropathy and Gastric Emptying

She has a lengthy medical history of diabetes and has been experiencing nausea after eating, along with a feeling of fullness and a reduced appetite. These symptoms suggest that she may be experiencing reduced gastric emptying, which is a common symptom of autonomic neuropathy. Other symptoms that may be present include postural hypotension, gustatory sweating, diarrhea, or changes in bowel habits. To confirm the diagnosis, a barium swallow and meal may be necessary.

Implanon and Nexplanon are both subdermal contraceptive implants that slowly release the hormone etonogestrel to prevent ovulation and thicken cervical mucous. Nexplanon is an updated version of Implanon with a redesigned applicator to prevent deep insertions and is radiopaque for easier location. It is highly effective with a failure rate of 0.07/100 women-years and lasts for 3 years. It doesn’t contain estrogen, making it suitable for women with a history of thromboembolism or migraines. It can be inserted immediately after a termination of pregnancy. However, a trained professional is needed for insertion and removal, and additional contraception is required for the first 7 days if not inserted on days 1-5 of the menstrual cycle.

The main disadvantage of these implants is irregular and heavy bleeding, which can be managed with a co-prescription of the combined oral contraceptive pill. Other adverse effects include headache, nausea, and breast pain. Enzyme-inducing drugs may reduce the efficacy of Nexplanon, and women should switch to a different method or use additional contraception until 28 days after stopping the treatment. Contraindications include ischaemic heart disease/stroke, unexplained vaginal bleeding, past breast cancer, severe liver cirrhosis, and liver cancer. Breast cancer is a UKMEC 4 condition, meaning it represents an unacceptable risk if the contraceptive method is used.

When a variable is measured to be extreme initially, it is likely to move closer to the average on subsequent measurements, which is known as regression to the mean.

Understanding the Placebo Effect

The placebo effect refers to the phenomenon where a patient experiences an improvement in their condition after receiving an inert substance or treatment that has no inherent pharmacological activity. This can include a sugar pill or a sham procedure that mimics a real medical intervention. The placebo effect is influenced by various factors, such as the perceived strength of the treatment, the status of the treating professional, and the patient’s expectations.

It is important to note that the placebo effect is not the same as receiving no care, as patients who maintain contact with medical services tend to have better outcomes. The placebo response is also greater in mild illnesses and can be difficult to separate from spontaneous remission. Patients who enter randomized controlled trials (RCTs) are often acutely unwell, and their symptoms may improve regardless of the intervention.

The placebo effect has been extensively studied in depression, where it tends to be abrupt and early in treatment, and less likely to persist compared to improvement from antidepressants. Placebo sag refers to a situation where the placebo effect is diminished with repeated use.

Overall, the placebo effect is a complex phenomenon that is influenced by various factors and can have significant implications for medical research and treatment. Understanding the placebo effect can help healthcare professionals provide better care and improve patient outcomes.

Patients with suspected temporomandibular joint dysfunction should be encouraged to practice early self-management techniques to control their symptoms and limit functional impairment. These techniques include using simple analgesics like paracetamol or ibuprofen, applying heat packs to the affected area, and avoiding hard or crunchy foods that can exacerbate the pain. With proper self-management, patients can expect to recover within 2-3 months.

If temporal arteritis is suspected, investigations such as ESR and temporal biopsy may be necessary. This condition presents with a throbbing headache, an obvious temporal artery, and claudication when chewing, and requires immediate treatment with corticosteroids to prevent vision loss.

While referral to a dentist may be necessary if self-management techniques are ineffective, an x-ray of the mandible is not required for diagnosis. Strong analgesia and opioids should be avoided, as simple analgesia is just as effective and carries fewer risks. X-rays are also unnecessary, as TMJ dysfunction is a clinical diagnosis that doesn’t require imaging to manage.

Understanding Temporomandibular Joint Dysfunction

Temporomandibular joint dysfunction (TMJ) is a condition that affects the jaw joint and the muscles that control its movement. It is characterized by pain in the TMJ area, which may radiate to the head, neck, or ear. Patients may also experience restricted jaw motion, making it painful to chew or speak. Additionally, they may notice clicking or other noises when moving their jaw.

To manage TMJ, healthcare professionals may recommend soft foods to reduce the strain on the jaw. Simple analgesia, such as paracetamol and NSAIDs, can also help alleviate pain. Short courses of benzodiazepines may be prescribed to help relax the muscles and reduce anxiety. It is also important to seek a review by a dentist to rule out any dental issues that may be contributing to the condition.

In summary, TMJ is a painful condition that affects the jaw joint and muscles. It can be managed through a combination of lifestyle changes, medication, and dental care. By understanding the symptoms and seeking appropriate treatment, patients can improve their quality of life and reduce the impact of TMJ on their daily activities.

Generalised anxiety disorder is more likely to occur in individuals who are divorced or separated, as well as those who are aged 35-54, living alone, or a lone parent. Conversely, being married or cohabiting and aged 16-24 are protective factors against the development of GAD. It is important to note that having a hyperthyroid disease or atrial fibrillation may cause symptoms similar to GAD, but they do not increase the risk of developing the disorder.

Anxiety is a common disorder that can manifest in various ways. According to NICE, the primary feature is excessive worry about multiple events associated with heightened tension. It is crucial to consider potential physical causes when diagnosing psychiatric disorders such as anxiety. Hyperthyroidism, cardiac disease, and medication-induced anxiety are important alternative causes. Medications that may trigger anxiety include salbutamol, theophylline, corticosteroids, antidepressants, and caffeine.

NICE recommends a stepwise approach for managing generalised anxiety disorder (GAD). The first step is education about GAD and active monitoring. The second step involves low-intensity psychological interventions such as individual non-facilitated self-help, individual guided self-help, or psychoeducational groups. The third step includes high-intensity psychological interventions such as cognitive behavioural therapy or applied relaxation, or drug treatment. Sertraline is the first-line SSRI recommended by NICE. If sertraline is ineffective, an alternative SSRI or a serotonin–noradrenaline reuptake inhibitor (SNRI) such as duloxetine or venlafaxine may be offered. If the person cannot tolerate SSRIs or SNRIs, pregabalin may be considered. For patients under the age of 30 years, NICE recommends warning them of the increased risk of suicidal thinking and self-harm and weekly follow-up for the first month.

The management of panic disorder also follows a stepwise approach. The first step is recognition and diagnosis, followed by treatment in primary care. NICE recommends either cognitive behavioural therapy or drug treatment. SSRIs are the first-line treatment. If contraindicated or no response after 12 weeks, imipramine or clomipramine should be offered. The third step involves reviewing and considering alternative treatments, followed by review and referral to specialist mental health services in the fourth and fifth steps, respectively.

Patients who have developed skin changes due to varicose veins, such as pigmentation and eczema, should be referred to secondary care.

Understanding Varicose Veins

Varicose veins are enlarged and twisted veins that occur when the valves in the veins become weak or damaged, causing blood to flow backward and pool in the veins. They are most commonly found in the legs and can be caused by various factors such as age, gender, pregnancy, obesity, and genetics. While many people seek treatment for cosmetic reasons, others may experience symptoms such as aching, throbbing, and itching. In severe cases, varicose veins can lead to skin changes, bleeding, superficial thrombophlebitis, and venous ulceration.

To diagnose varicose veins, a venous duplex ultrasound is typically performed to detect retrograde venous flow. Treatment options vary depending on the severity of the condition. Conservative treatments such as leg elevation, weight loss, regular exercise, and compression stockings may be recommended for mild cases. However, patients with significant or troublesome symptoms, skin changes, or a history of bleeding or ulcers may require referral to a specialist for further evaluation and treatment. Possible treatments include endothermal ablation, foam sclerotherapy, or surgery.

In summary, varicose veins are a common condition that can cause discomfort and cosmetic concerns. While many cases do not require intervention, it is important to seek medical attention if symptoms or complications arise. With proper diagnosis and treatment, patients can manage their condition and improve their quality of life.

Understanding Variceal Haemorrhage: Causes, Complications, and Prognosis

Variceal haemorrhage is a common complication of portal hypertension, with almost 90% of cirrhosis patients developing varices and 30% experiencing bleeding. The mortality rate for the first episode is high, ranging from 30-50%. The severity of liver disease and associated systemic disorders worsen the prognosis, increasing the likelihood of a bleed. Patients who have had one episode of bleeding have a high chance of recurrence within a year, with one-third of further episodes being fatal. While abstaining from alcohol can slow the progression of liver disease, it cannot reverse portal hypertension. Understanding the causes, complications, and prognosis of variceal haemorrhage is crucial for effective management and prevention.

Vitamin B12 is essential for the development of red blood cells and the maintenance of the nervous system. It is absorbed through the binding of intrinsic factor, which is secreted by parietal cells in the stomach, and actively absorbed in the terminal ileum. A deficiency in vitamin B12 can be caused by pernicious anaemia, post gastrectomy, a vegan or poor diet, disorders or surgery of the terminal ileum, Crohn’s disease, or metformin use.

Symptoms of vitamin B12 deficiency include macrocytic anaemia, a sore tongue and mouth, neurological symptoms, and neuropsychiatric symptoms such as mood disturbances. The dorsal column is usually affected first, leading to joint position and vibration issues before distal paraesthesia.

Management of vitamin B12 deficiency involves administering 1 mg of IM hydroxocobalamin three times a week for two weeks, followed by once every three months if there is no neurological involvement. If a patient is also deficient in folic acid, it is important to treat the B12 deficiency first to avoid subacute combined degeneration of the cord.

Chlorine salicylate gel

Coeliac Disease in Children

Coeliac disease is a condition that affects young children, typically presenting by the age of 2 with failure to thrive. This occurs when gluten is introduced into their diet through the consumption of cereals. Symptoms include irritability, abdominal distention, buttock wasting, and abnormal stools due to malabsorption. Children can also present later on in childhood with anaemia or failure to thrive with very subtle or no gastrointestinal symptoms.

Diagnosis requires a jejunal biopsy for histological confirmation, and treatment is with a gluten-free diet. There appears to be a genetic link, and first-degree relatives of people with coeliac disease have a 1 in 10 chance of having the disease. Patients with coeliac disease also have a higher risk of type 1 diabetes, thyroid disease, and other autoimmune diseases.

It is important to consider offering testing (by tTG antibody testing) to first-degree relatives because a strict gluten-free diet is essential in reducing the associated risk of GI malignancy, especially lymphoma, in people with coeliac disease.

Differential Diagnosis for a Patient with Flu-like Symptoms and Jaundice

Hepatitis A is a vaccine-preventable infection commonly acquired during travel. It spreads through contaminated food and presents with flu-like symptoms followed by jaundice and dark urine. Biliary colic may cause right upper quadrant pain but is unlikely to cause fever or significantly raised liver transaminase levels. Hepatitis B is transmitted through sexual contact, needle sharing, blood transfusions, organ transplantation, or from mother to child during delivery. Pancreatic carcinoma presents with weight loss, obstructive jaundice, mid-epigastric or back pain, and disproportionately raised alkaline phosphatases levels. Salmonella enteritidis causes food poisoning with diarrhea, fever, and colicky abdominal pain.

DEET is safe to use topically on infants as young as 2 months old, as well as pregnant and breastfeeding women. It effectively repels mosquitos and can prevent tick attachment for up to 12 hours after application. However, it doesn’t offer any sun protection. To ensure proper protection, it is recommended to apply sunscreen first and then apply DEET on top.

Malaria is a serious disease caused by the Plasmodium falciparum protozoa, with around 1,500-2,000 cases reported each year in patients returning from endemic countries. The majority of these cases occur in patients who did not take prophylaxis. It is important to consult up-to-date charts for recommended regimens for malaria zones before prescribing. There are several drugs available for prophylaxis, including Atovaquone + proguanil (Malarone), Chloroquine, Doxycycline, Mefloquine (Lariam), and Proguanil (Paludrine). Pregnant women and children are at higher risk of serious complications and should avoid travel to malaria endemic regions if possible. However, if travel is essential, prophylaxis should be taken, and DEET can be used to repel mosquitoes. Doxycycline is only licensed for use in children over the age of 12 years.

Cataract as a Cause of Reduced Acuity

A patient with reduced acuity that improves with pinhole may have a refractive error caused by cataract. If the red reflex is duller in one eye, cataract in that eye should be considered as a possible diagnosis. Cataracts that significantly affect quality of life should be referred to ophthalmology for evaluation of cataract surgery and future visual rehabilitation.

It is important to note that referral guidance may vary by region, but for the purpose of examination questions, candidates should answer based on national consensus opinion.

The most likely diagnosis for this man with biochemical evidence of hypothyroidism and raised anti-TPO antibodies is Hashimoto’s thyroiditis, which is characterized by hypothyroidism, goitre, and anti-TPO antibodies. Exophthalmos, hypercalcaemia, and onycholysis are not typically associated with Hashimoto’s thyroiditis, but rather with other thyroid disorders such as Graves’ disease.

Understanding Hashimoto’s Thyroiditis

Hashimoto’s thyroiditis is a chronic autoimmune disorder that affects the thyroid gland. It is more common in women and is typically associated with hypothyroidism, although there may be a temporary period of thyrotoxicosis during the acute phase. The condition is characterized by a firm, non-tender goitre and the presence of anti-thyroid peroxidase (TPO) and anti-thyroglobulin (Tg) antibodies.

Hashimoto’s thyroiditis is often associated with other autoimmune conditions such as coeliac disease, type 1 diabetes mellitus, and vitiligo. Additionally, there is an increased risk of developing MALT lymphoma with this condition. It is important to note that many causes of hypothyroidism may have an initial thyrotoxic phase, as shown in the Venn diagram. Understanding the features and associations of Hashimoto’s thyroiditis can aid in its diagnosis and management.

Understanding the Risk Factors for Developing Breast Cancer

Breast cancer is a prevalent disease that affects 1.4% of the overall population. However, the risk of developing breast cancer increases with a family history of the disease. The number of affected first-degree relatives and their age at diagnosis can significantly impact the risk. For instance, having one affected first-degree relative increases the risk to 4-5%, while having two close relatives affected raises the risk to 7%.

Women with BRCA1 mutation have a 40% carrier risk of developing carcinoma, while those with BRCA2 have a 25% risk. Additionally, women who have had many ovulations, early menarche, and nullipara are more likely to develop breast cancer. However, the use of the combined oral contraceptive pill is associated with a reduced risk of developing the disease.

In summary, understanding the risk factors for developing breast cancer is crucial in taking preventive measures and seeking early diagnosis and treatment.

Treatment Options for Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a common condition in older men that can cause urinary symptoms. Here are some common treatment options and their effectiveness:

Alpha-blockers: These medications, such as tamsulosin, relax smooth muscle and are the first-line treatment for patients with predominantly voiding symptoms.

Transurethral resection of the prostate (TURP): Surgery is reserved for patients with bladder outflow obstruction or in those in whom medical therapy fails.

Finasteride: This medication shrinks the prostate, but the benefit is seen over weeks to months.

Prostate biopsy: This should be considered in the investigation of prostate cancer, but is not necessary in this patient with normal PSA and examination findings.

Saw palmetto: This herbal remedy is not more effective than placebo and is not recommended by NICE.

Confidential Medical Records for Adolescents

When it comes to disclosing confidential medical records of a 15-year-old adolescent, it is important to consider their maturity level. If they are deemed ‘Gillick’ competent, then their decision to disclose or withhold their medical record should be respected. However, practitioners must carefully review any third-party information and any information that may cause harm to an individual’s physical or mental health. If necessary, this information can be withheld under the Data Protection Act 1998. It is crucial to handle confidential medical records with care to protect the privacy and well-being of adolescents.

Patients with intractable spasticity in adults with multiple sclerosis may undergo a trial of THC:CBD spray, a medicinal product derived from cannabis. CKS suggests a 4 week trial for those with moderate to severe spasticity who have not found relief from other treatments, under the supervision of a specialist. Other treatments are not recommended.

Cannabis-Based Medicinal Products: Guidelines and Available Products

Cannabis-based medicinal products can now be prescribed for therapeutic use under specialist supervision, following a Department of Health review in 2018. These products are defined as medicinal preparations or products that contain cannabis, cannabis resin, cannabinol, or a cannabinol derivative, and are produced for use in humans. Initial prescriptions must be made by a specialist medical practitioner with experience in the condition being treated, and subsequent prescriptions can be issued by another practitioner under a shared care agreement.

Cannabis-based medicinal products can be used to manage various conditions, including chemotherapy-induced nausea and vomiting, chronic pain, spasticity in adults with multiple sclerosis, and severe-treatment resistant epilepsy. However, current NICE guidance advises against using cannabis-based medicines for chronic pain, except if already initiated and under specialist supervision until appropriate to stop.

Several cannabis-based products and cannabinoids are available, including Bedrocan, Tilray, Sativex, Epidiolex, Dronabinol, and Nabilone. However, unlicensed cannabis-based products can only be prescribed by doctors on the General Medical Council Specialist Register, and doctors should prescribe products only for disorders within their specialty when there is clear evidence or published guidelines.

It is important to consider current available evidence, interactions with other prescribed or non-prescribed medication, and the potential for patients to seek or use non-medicinal products lacking safety and quality assurance when considering prescribing cannabis-based products. Patients should also be advised of the risks of impaired driving, as cannabis-based products may impair a patient’s ability to drive safely.

Common side effects associated with cannabis-based medicines include disorientation, dizziness, euphoria, confusion, dry mouth, nausea, somnolence, fatigue, vomiting, drowsiness, loss of balance, and hallucination. Rare adverse events include psychosis and seizures.